156 related articles for article (PubMed ID: 22209942)
1. CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells.
Yu JH; Zhong XY; Zhang WG; Wang ZD; Dong Q; Tai S; Li H; Cui YF
Oncol Rep; 2012 Apr; 27(4):1266-76. PubMed ID: 22209942
[TBL] [Abstract][Full Text] [Related]
2. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas.
You Y; Yang W; Wang Z; Zhu H; Li H; Lin C; Ran Y
Cell Oncol (Dordr); 2013 Jul; 36(4):323-31. PubMed ID: 23740091
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological significance of Cdk10 in hepatocellular carcinoma.
Zhong XY; Xu XX; Yu JH; Jiang GX; Yu Y; Tai S; Wang ZD; Cui YF
Gene; 2012 Apr; 498(1):68-74. PubMed ID: 22326270
[TBL] [Abstract][Full Text] [Related]
5. Downregulated CDK10 expression in gastric cancer: Association with tumor progression and poor prognosis.
You Y; Bai F; Ye Z; Zhang N; Yao L; Tang Y; Li X
Mol Med Rep; 2018 May; 17(5):6812-6818. PubMed ID: 29512714
[TBL] [Abstract][Full Text] [Related]
6. Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer.
Iorns E; Turner NC; Elliott R; Syed N; Garrone O; Gasco M; Tutt AN; Crook T; Lord CJ; Ashworth A
Cancer Cell; 2008 Feb; 13(2):91-104. PubMed ID: 18242510
[TBL] [Abstract][Full Text] [Related]
7. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Mayr C; Wagner A; Loeffelberger M; Bruckner D; Jakab M; Berr F; Di Fazio P; Ocker M; Neureiter D; Pichler M; Kiesslich T
Oncotarget; 2016 Jan; 7(1):745-58. PubMed ID: 26623561
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the Kinase Domain of CDK10 Prevents Tumor Growth in a Preclinical Model of Colorectal Cancer, and Is Accompanied by Downregulation of Bcl-2.
Weiswald LB; Hasan MR; Wong JCT; Pasiliao CC; Rahman M; Ren J; Yin Y; Gusscott S; Vacher S; Weng AP; Kennecke HF; Bièche I; Schaeffer DF; Yapp DT; Tai IT
Mol Cancer Ther; 2017 Oct; 16(10):2292-2303. PubMed ID: 28663269
[TBL] [Abstract][Full Text] [Related]
9. Cyclin‑dependent kinase 10 prevents glioma metastasis via modulation of Snail expression.
Li H; You Y; Liu J
Mol Med Rep; 2018 Jul; 18(1):1165-1170. PubMed ID: 29845196
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of cyclin-dependent kinase 10 (cdk10) gene impairs neural progenitor survival via modulation of raf1a gene expression.
Yeh CW; Kao SH; Cheng YC; Hsu LS
J Biol Chem; 2013 Sep; 288(39):27927-39. PubMed ID: 23902762
[TBL] [Abstract][Full Text] [Related]
11. Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study.
Hong CQ; Zhang F; You YJ; Qiu WL; Giuliano AE; Cui XJ; Zhang GJ; Cui YK
BMC Cancer; 2015 Jul; 15():548. PubMed ID: 26209438
[TBL] [Abstract][Full Text] [Related]
12. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
[TBL] [Abstract][Full Text] [Related]
13. Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.
Zimmermann M; Arachchige-Don AP; Donaldson MS; Patriarchi T; Horne MC
Cell Cycle; 2016 Dec; 15(23):3278-3295. PubMed ID: 27753529
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression.
Zhong XY; Yu JH; Zhang WG; Wang ZD; Dong Q; Tai S; Cui YF; Li H
Gene; 2012 Feb; 493(1):44-51. PubMed ID: 22146319
[TBL] [Abstract][Full Text] [Related]
15. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
16. CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene.
Bazzi ZA; Tai IT
Front Oncol; 2021; 11():655479. PubMed ID: 34277407
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of the human Cdk10/Cyclin Q complex.
Düster R; Ji Y; Pan KT; Urlaub H; Geyer M
Open Biol; 2022 Mar; 12(3):210381. PubMed ID: 35291876
[TBL] [Abstract][Full Text] [Related]
18. CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.
Zhang X; Zhao Y; Yiminniyaze R; Zhu N; Zhang Y; Wumaier G; Xia J; Dong L; Zhou D; Wang J; Li C; Zhang Y; Li S
Mol Carcinog; 2024 Jan; 63(1):61-74. PubMed ID: 37737453
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
Nam AR; Jin MH; Park JE; Bang JH; Oh DY; Bang YJ
Cancer Res Treat; 2019 Jul; 51(3):1167-1179. PubMed ID: 30514066
[TBL] [Abstract][Full Text] [Related]
20. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
